Adhera Therapeutics (ATRX) - Strategic SWOT Analysis Review

Adhera Therapeutics (ATRX) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the companys key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy summarization of the companys business strategy.
- SWOT analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details.

Highlights

Adhera Therapeutics (Adhera) is a biopharmaceutical company that leverages technologies to commercialize unique therapies in improving the patient outcomes. Its flagship product Prestalia is a fixed dose combination of perindopril arginine and amlodipine besylate. Prestalia is approved by the US-FDA and is used in the treatment of hypertension to lower blood pressure. Prestalia is sold under the brand name Coveram or Viacoram outside the US. The company also offers Total Care System through its DyrctAxess patented technology platform. Adhera sells products through wholesale pharmaceutical distributors and pharmacies. Adhera is headquartered in Durham, North Carolina, the US.

Adhera Therapeutics Key Recent Developments

Apr 04,2019: Adhera Therapeutics appoints Nancy Phelan as Chief Executive Officer
Nov 20,2018: Adhera Therapeutics selects IQVIAs OCE technology platform to support commercial excellence
Nov 20,2018: Adhera Therapeutics provides third quarter 2018 financial results and business update
Aug 06,2018: Marina Biotech appoints Jay D. Schwartz to serve as senior vice president, commercial operations
Jun 29,2018: Marina Biotech Names Uli Hacksell And Robert C. Moscato As Board Directors

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors business structure and strategies with detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this reports detailed insight into the companys strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.


List of Tables
List of Figures
Section 1 - About the Company
Adhera Therapeutics - Key Facts
Adhera Therapeutics - Key Employees
Adhera Therapeutics - Key Employee Biographies
Adhera Therapeutics - Major Products and Services
Adhera Therapeutics - History
Adhera Therapeutics - Company Statement
Adhera Therapeutics - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 Company Analysis
Company Overview
Adhera Therapeutics - Business Description
Adhera Therapeutics - Corporate Strategy
Adhera Therapeutics - SWOT Analysis
SWOT Analysis - Overview
Adhera Therapeutics - Strengths
Adhera Therapeutics - Weaknesses
Adhera Therapeutics - Opportunities
Adhera Therapeutics - Threats
Adhera Therapeutics - Key Competitors
Section 3 Companys Lifesciences Financial Deals and Alliances
Adhera Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Adhera Therapeutics, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Adhera Therapeutics, Recent Deals Summary
Section 4 Companys Recent Developments
Apr 04, 2019: Adhera Therapeutics appoints Nancy Phelan as Chief Executive Officer
Nov 20, 2018: Adhera Therapeutics selects IQVIAs OCE technology platform to support commercial excellence
Nov 20, 2018: Adhera Therapeutics provides third quarter 2018 financial results and business update
Aug 06, 2018: Marina Biotech appoints Jay D. Schwartz to serve as senior vice president, commercial operations
Jun 29, 2018: Marina Biotech Names Uli Hacksell And Robert C. Moscato As Board Directors
Jun 20, 2018: Marina Biotech Appoints Robert Moscato to Chief Executive Officer
Section 5 Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables


Adhera Therapeutics, Key Facts
Adhera Therapeutics, Key Employees
Adhera Therapeutics, Key Employee Biographies
Adhera Therapeutics, Major Products and Services
Adhera Therapeutics, History
Adhera Therapeutics, Subsidiaries
Adhera Therapeutics, Key Competitors
Adhera Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Adhera Therapeutics, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Adhera Therapeutics, Recent Deals Summary

List Of Figures


Adhera Therapeutics, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Adhera Therapeutics, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

Adhera Therapeutics (ATRX) - Strategic SWOT Analysis Review

Adhera Therapeutics (ATRX) - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Adhera Therapeutics (MRNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adhera Therapeutics (Adhera) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using

USD 250 View Report

Adhera Therapeutics (MRNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Adhera Therapeutics (Adhera) is a nucleic acid-based drug discovery and development company that focuses on rare diseases. It focuses on treating the intersection of arthritis, hypertension, pain, and cancer using

USD 250 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available